Core Scientific (NASDAQ:CORZ) Upgraded to “Buy” at Needham & Company LLC

Needham & Company LLC upgraded shares of Core Scientific (NASDAQ:CORZ) from a hold rating to a buy rating in a research report report published on Tuesday, Marketbeat Ratings reports. They currently have $23.00 price target on the stock.

Several other brokerages also recently issued reports on CORZ. Sanford C. Bernstein upped their price target on Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, November 3rd. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective on the stock in a report on Thursday, December 18th. Zacks Research upgraded shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 13th. BTIG Research raised shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. Finally, HC Wainwright restated a “buy” rating and set a $25.00 price target on shares of Core Scientific in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $24.66.

Core Scientific Stock Performance

Shares of NASDAQ CORZ opened at $15.30 on Tuesday. The stock has a market cap of $4.74 billion, a price-to-earnings ratio of 13.08 and a beta of 6.87. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63. The firm’s 50-day simple moving average is $17.27 and its 200 day simple moving average is $16.96.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Monday, March 2nd. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.69. The company had revenue of $79.76 million for the quarter, compared to the consensus estimate of $118.45 million. The business’s revenue for the quarter was down 16.0% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.69) earnings per share. On average, sell-side analysts predict that Core Scientific will post 0.52 EPS for the current year.

Hedge Funds Weigh In On Core Scientific

Several institutional investors have recently bought and sold shares of the company. Allworth Financial LP grew its stake in shares of Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the period. Larson Financial Group LLC raised its stake in Core Scientific by 936.7% in the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock valued at $27,000 after acquiring an additional 1,686 shares during the period. HHM Wealth Advisors LLC lifted its holdings in Core Scientific by 96.5% during the second quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock valued at $33,000 after purchasing an additional 946 shares during the last quarter. Osaic Holdings Inc. lifted its holdings in Core Scientific by 112.1% during the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after purchasing an additional 1,066 shares during the last quarter. Finally, Danske Bank A S bought a new position in Core Scientific during the fourth quarter worth about $36,000.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Unusually large options activity — traders bought ~188,642 call options (≈51% above normal call volume), signalling aggressive bullish positioning from some market participants.
• Positive Sentiment: Colocation revenue surge — management reported colocation revenue grew dramatically (reported +268% year-over-year), supporting the company’s transition from BTC mining toward AI/colocation demand. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
• Positive Sentiment: Analyst upgrades and high targets — Needham upgraded CORZ to Buy with a $23 target (~+50% implied upside), HC Wainwright reaffirmed Buy with $25, and Cantor Fitzgerald kept an Overweight with a $25 target; these actions reinforce a bullish analyst tone despite some target trims. Needham Upgrade
• Neutral Sentiment: Mixed quarter — CORZ reported $0.42 EPS (beat consensus) but revenue of $79.8M missed estimates (~$118M), so profitability signals improved while top-line momentum is weak; management emphasized progress on a 1.5 GW leasable pipeline. Business Wire: Q4 Results
• Neutral Sentiment: Full disclosure and detail sources — earnings slide deck and call transcript are available for investors who want to dig into guidance, margin dynamics, and contract backlog. Earnings Presentation
• Negative Sentiment: Revenue miss and reported loss — some outlets highlight the Q4 revenue miss and a quarterly loss (Zacks coverage), raising near-term concern about top-line pacing while the company reinvests for AI/colocation growth. Zacks: Q4 Loss, Revenue Miss
• Negative Sentiment: Immediate market reaction — coverage notes CORZ shares slid after the report and as the company pushes a sizable infrastructure expansion (1.5 GW), highlighting investor worry about near-term cash burn and execution risk. Blockonomi: Stock Slides
• Neutral Sentiment: Short-interest data appears unreliable in recent feeds (showing zeros/NaN); no clear short-squeeze signal from public short-interest figures at this time.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.